BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK WITH DIMINISHED IMID ACTIVITY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240336595A1
SERIAL NO

18579114

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This disclosure relates to compounds useful for degrading BTK via a ubiquitin proteolytic pathway with little or no IMiD activity. The description also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NURIX THERAPEUTICS INC1700 OWENS STREET SUITE 205 SAN FRANCISCO CA 94158

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Guiducci, Cristiana San Francisco, US 21 101
Noviski, Mark San Francisco, US 2 0
Powers, Janine San Francisco, US 13 55
Rountree, Ryan San Francisco, US 9 74
Tan, Ying Siow San Francisco, US 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation